PRK vs UTHR · P/E 16, rev $400.4M vs P/E 20, rev $1.56B
Park National Corporation (PRK) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Park National Corporation (PRK) is a banks - regional company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported PRK revenue for 2026-06-30 was $400.4M. Net income was $100.4M. PRK currently screens at market cap $3.13B and trailing P/E 15.9.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
PRK currently screens at market cap $3.13B and trailing P/E 15.9. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the PRK and UTHR stock pages for the full models.
Not investment advice.